Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Clinical Neuromuscular Disease is Scopus-indexed (Q3, CiteScore 1.7). It is covered by India's One Nation One Subscription scheme for reading access. Published by Lippincott Williams and Wilkins.
Checked against the index lists dated .
ISSN 1522-0443Verify ISSN ↗1537-1611Verify ISSN ↗
Publisher: Lippincott Williams and Wilkins
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Neurology (clinical) | 293 / 403 | 27th | Q3 |
| Neurology | 147 / 201 | 27th | Q3 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1999–present, best quartile Q3, CiteScore 1.7.
Journal of Clinical Neuromuscular Disease is Q3 in Neurology (clinical) (rank 293 of 403) and Q3 in Neurology (rank 147 of 201), by CiteScore 2025.
Journal of Clinical Neuromuscular Disease is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.7, quartile Q3, 27th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.282, quartile Q3, with an H-index of 37.
Journal of Clinical Neuromuscular Disease is published by Lippincott Williams and Wilkins. Its print ISSN is 1522-0443 and its online ISSN is 1537-1611.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Clinical Neuromuscular Disease has an h-index of 43 and a 2-year mean of 0.75 citations per paper (OpenAlex). Its Scopus CiteScore is 1.7, quartile Q3. On 2-year citations it ranks #296 of 403 Scopus journals in Neurology (clinical).
Journal of Clinical Neuromuscular Disease published 33 papers in 2025; its busiest recent year was 2021 with 52. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 92 research articles (2024–2026), authors are most often from United States (59.2%), India (4.7%) and United Kingdom (4.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.